Arcus Biosciences Stock Market Value
| RCUS Stock | USD 16.44 0.50 3.14% |
| Symbol | Arcus |
Arcus Biosciences Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arcus Biosciences. If investors know Arcus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arcus Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.19) | Revenue Per Share 3.058 | Quarterly Revenue Growth 0.5 | Return On Assets (0.15) | Return On Equity (0.50) |
The market value of Arcus Biosciences is measured differently than its book value, which is the value of Arcus that is recorded on the company's balance sheet. Investors also form their own opinion of Arcus Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Arcus Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arcus Biosciences' market value can be influenced by many factors that don't directly affect Arcus Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arcus Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arcus Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arcus Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Arcus Biosciences 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Arcus Biosciences' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Arcus Biosciences.
| 06/07/2024 |
| 12/04/2024 |
If you would invest 0.00 in Arcus Biosciences on June 7, 2024 and sell it all today you would earn a total of 0.00 from holding Arcus Biosciences or generate 0.0% return on investment in Arcus Biosciences over 180 days. Arcus Biosciences is related to or competes with Cullinan Oncology, Annexon, Structure Therapeutics, Relay Therapeutics, Day One, Acumen Pharmaceuticals, and X4 Pharmaceuticals. Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the... More
Arcus Biosciences Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Arcus Biosciences' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Arcus Biosciences upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.55 | |||
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 17.22 | |||
| Value At Risk | (5.85) | |||
| Potential Upside | 7.43 |
Arcus Biosciences Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arcus Biosciences' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Arcus Biosciences' standard deviation. In reality, there are many statistical measures that can use Arcus Biosciences historical prices to predict the future Arcus Biosciences' volatility.| Risk Adjusted Performance | 0.0082 | |||
| Jensen Alpha | (0.19) | |||
| Total Risk Alpha | (0.49) | |||
| Sortino Ratio | (0.03) | |||
| Treynor Ratio | (0) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arcus Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Arcus Biosciences Backtested Returns
Currently, Arcus Biosciences is not too volatile. Arcus Biosciences secures Sharpe Ratio (or Efficiency) of 0.0256, which signifies that the company had a 0.0256% return per unit of standard deviation over the last 3 months. We have found thirty technical indicators for Arcus Biosciences, which you can use to evaluate the volatility of the firm. Please confirm Arcus Biosciences' mean deviation of 2.67, and Risk Adjusted Performance of 0.0082 to double-check if the risk estimate we provide is consistent with the expected return of 0.093%. Arcus Biosciences has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.75, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Arcus Biosciences will likely underperform. Arcus Biosciences right now shows a risk of 3.63%. Please confirm Arcus Biosciences downside variance, and the relationship between the total risk alpha and daily balance of power , to decide if Arcus Biosciences will be following its price patterns.
Auto-correlation | -0.29 |
Weak reverse predictability
Arcus Biosciences has weak reverse predictability. Overlapping area represents the amount of predictability between Arcus Biosciences time series from 7th of June 2024 to 5th of September 2024 and 5th of September 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Arcus Biosciences price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Arcus Biosciences price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | 0.02 | |
| Residual Average | 0.0 | |
| Price Variance | 1.17 |
Arcus Biosciences lagged returns against current returns
Autocorrelation, which is Arcus Biosciences stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Arcus Biosciences' stock expected returns. We can calculate the autocorrelation of Arcus Biosciences returns to help us make a trade decision. For example, suppose you find that Arcus Biosciences has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Arcus Biosciences regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Arcus Biosciences stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Arcus Biosciences stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Arcus Biosciences stock over time.
Current vs Lagged Prices |
| Timeline |
Arcus Biosciences Lagged Returns
When evaluating Arcus Biosciences' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Arcus Biosciences stock have on its future price. Arcus Biosciences autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Arcus Biosciences autocorrelation shows the relationship between Arcus Biosciences stock current value and its past values and can show if there is a momentum factor associated with investing in Arcus Biosciences.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Arcus Stock Analysis
When running Arcus Biosciences' price analysis, check to measure Arcus Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arcus Biosciences is operating at the current time. Most of Arcus Biosciences' value examination focuses on studying past and present price action to predict the probability of Arcus Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arcus Biosciences' price. Additionally, you may evaluate how the addition of Arcus Biosciences to your portfolios can decrease your overall portfolio volatility.